{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:06:59Z","timestamp":1778818019103,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.hfc.2011.03.009","type":"journal-article","created":{"date-parts":[[2011,5,24]],"date-time":"2011-05-24T11:19:10Z","timestamp":1306235950000},"page":"385-393","source":"Crossref","is-referenced-by-count":14,"title":["Amyloidotic Cardiomyopathy: Multidisciplinary Approach to Diagnosis and Treatment"],"prefix":"10.1016","volume":"7","author":[{"given":"David C.","family":"Seldin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L.","family":"Berk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flora","family":"Sam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaishali","family":"Sanchorawala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.hfc.2011.03.009_bib1","first-page":"72","article-title":"The changing face of AA amyloidosis: a single centre experience","volume":"17","author":"Girnius","year":"2010","journal-title":"Amyloid"},{"key":"10.1016\/j.hfc.2011.03.009_bib2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/13506120009146826","article-title":"Tabulation of transthyretin (TTR) variants as of 1\/1\/2000","volume":"7","author":"Connors","year":"2000","journal-title":"Amyloid"},{"key":"10.1016\/j.hfc.2011.03.009_bib3","first-page":"703","article-title":"Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis","volume":"73","author":"Gustavsson","year":"1995","journal-title":"Lab Invest"},{"key":"10.1016\/j.hfc.2011.03.009_bib4","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.amjcard.2008.09.105","article-title":"Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis","volume":"103","author":"Ruberg","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2011.03.009_bib5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s002590050272","article-title":"Scintigraphic imaging and turnover studies with iodine-131 labeled serum amyloid P component in systemic amyloidosis","volume":"25","author":"Hawkins","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.hfc.2011.03.009_bib6","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/archinte.1983.00350080055015","article-title":"Use of abdominal fat tissue aspirate in the diagnosis of systemic amyloidosis","volume":"143","author":"Libbey","year":"1983","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hfc.2011.03.009_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/hrt.78.1.74","article-title":"Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes","volume":"78","author":"Dubrey","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2011.03.009_bib8","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/archinte.165.12.1425","article-title":"Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis","volume":"165","author":"Ng","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hfc.2011.03.009_bib9","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/01.RES.0000126569.75419.74","article-title":"Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress","volume":"94","author":"Brenner","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2011.03.009_bib10","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/circ.104.14.1594","article-title":"Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts","volume":"104","author":"Liao","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2011.03.009_bib11","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1073\/pnas.0912263107","article-title":"Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway","volume":"107","author":"Shi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hfc.2011.03.009_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/CIRCHEARTFAILURE.108.788687","article-title":"Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition","volume":"1","author":"Biolo","year":"2008","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hfc.2011.03.009_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbapap.2005.08.014","article-title":"Clinical aspects of systemic amyloid diseases","volume":"1753","author":"Obici","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.hfc.2011.03.009_bib14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajh.20381","article-title":"Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004","volume":"79","author":"Gertz","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hfc.2011.03.009_bib15","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1161\/01.CIR.0000068314.02595.B2","article-title":"Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis","volume":"107","author":"Palladini","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2011.03.009_bib16","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1200\/JCO.2004.03.029","article-title":"Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis","volume":"22","author":"Dispenzieri","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hfc.2011.03.009_bib17","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S0140-6736(03)13396-X","article-title":"Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins","volume":"361","author":"Dispenzieri","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2011.03.009_bib18","first-page":"167a","article-title":"Troponin as a prognostic marker in cardiac amyloidosis","volume":"17","author":"Apridonidze","year":"2010","journal-title":"Amyloid"},{"key":"10.1016\/j.hfc.2011.03.009_bib19","first-page":"48a","article-title":"Definition of organ involvement and response to treatment in AL amyloidosis: an updated consensus opinion","volume":"17","author":"Gertz","year":"2010","journal-title":"Amyloid"},{"key":"10.1016\/j.hfc.2011.03.009_bib20","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa070484","article-title":"High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis","volume":"357","author":"Jaccard","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2011.03.009_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-140-2-200401200-00008","article-title":"High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study","volume":"140","author":"Skinner","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hfc.2011.03.009_bib22","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.amjcard.2009.05.040","article-title":"Frequencies and types of arrhythmias in patients with systemic light-chain amyloidosis with cardiac involvement undergoing stem cell transplantation on telemetry monitoring","volume":"104","author":"Goldsmith","year":"2009","journal-title":"Am J Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.hfc.2011.03.009_bib23","first-page":"150","article-title":"Regression of cardiac wall thickness following chemotherapy and stem-cell transplantation for AL amyloidosis","volume":"17","author":"Meier-Ewert","year":"2010","journal-title":"Amyloid"},{"key":"10.1016\/j.hfc.2011.03.009_bib24","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1182\/blood-2003-08-2788","article-title":"Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation","volume":"103","author":"Palladini","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hfc.2011.03.009_bib25","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/ndt\/gfq482","article-title":"Kidney dysfunction during lenalidomide treatment for AL amyloidosis","volume":"26","author":"Specter","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.hfc.2011.03.009_bib26","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.2353\/ajpath.2010.090690","article-title":"Cardiotoxicity of the anticancer therapeutic agent bortezomib","volume":"176","author":"Nowis","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.hfc.2011.03.009_bib27","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ahj.2009.08.006","article-title":"Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis","volume":"158","author":"Connors","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2011.03.009_bib28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00007890-199707150-00014","article-title":"Progression of ventricular wall thickening after liver transplantation for familial amyloidosis","volume":"64","author":"Dubrey","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.hfc.2011.03.009_bib29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/13506120701614032","article-title":"Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation","volume":"14","author":"Liepnieks","year":"2007","journal-title":"Amyloid"},{"key":"10.1016\/j.hfc.2011.03.009_bib30","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1378\/chest.124.3.969","article-title":"Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis","volume":"124","author":"Berk","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.hfc.2011.03.009_bib31","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/0002-9149(85)90995-6","article-title":"Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents","volume":"55","author":"Gertz","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2011.03.009_bib32","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/0002-9149(85)90996-8","article-title":"Selective binding of nifedipine to amyloid fibrils","volume":"55","author":"Gertz","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2011.03.009_bib33","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1378\/chest.104.2.618","article-title":"Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis","volume":"104","author":"Pollak","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.hfc.2011.03.009_bib34","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.CIR.63.6.1285","article-title":"Digoxin sensitivity in amyloid cardiomyopathy","volume":"63","author":"Rubinow","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2011.03.009_bib35","first-page":"346","article-title":"Successful intermediate-term outcome for patients with cardiac amyloidosis undergoing heart transplantation: results of a multicenter survey","volume":"9","author":"Hosenpud","year":"1990","journal-title":"J\u00a0Heart Transplant"},{"key":"10.1016\/j.hfc.2011.03.009_bib36","first-page":"III338","article-title":"Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter survey","volume":"84","author":"Hosenpud","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2011.03.009_bib37","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/TP.0b013e3181f10edb","article-title":"Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure","volume":"90","author":"Dey","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.hfc.2011.03.009_bib38","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.healun.2008.05.016","article-title":"Autologous stem cell transplant after heart transplant for light chain (AL) amyloid cardiomyopathy","volume":"27","author":"Lacy","year":"2008","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hfc.2011.03.009_bib39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/eurheartj\/ehi040","article-title":"Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques","volume":"26","author":"Modesto","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2011.03.009_bib40","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1161\/CIRCULATIONAHA.108.785014","article-title":"Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis","volume":"119","author":"Feng","year":"2009","journal-title":"Circulation"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713611000304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713611000304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T03:15:30Z","timestamp":1560222930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713611000304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1551713611000304"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2011.03.009","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}